Global News

Galapagos acquires Cangenix

Wednesday, January 16, 2013 11:21 AM

Galapagos, a mid-size clinical stage biotechnology company, has acquired Cangenix, a gene-to-structure biotech company, to add structure-based drug discovery to its Argenta service offering. Cangenix's state-of-the-art technology will augment Argenta's ability to design new drugs and fill a growing client need.

More... »

Change to the Roche corporate executive committee

Wednesday, January 16, 2013 10:53 AM

Switzerland-based Roche has named John C. Reed, M.D., Ph.D., as its new head of Roche Pharma Research and Early Development (pRED) and member of the enlarged corporate executive committee.

More... »

ERT expands corporate presence in Japan

Wednesday, January 16, 2013 09:26 AM

ERT, a global technology-driven provider of health outcomes research services, has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group.

More... »

DeHaemer joins CSS as senior enrollment specialist role

Tuesday, January 15, 2013 08:00 AM

Clinical Site Services (CSS), a site performance company that provides solutions to increase the enrollment potential for investigative sites, has appointed Teresa DeHaemer as a senior enrollment specialist.

More... »

GSK submits albiglutide BLA to FDA for T2D

Monday, January 14, 2013 02:20 PM

GlaxoSmithKline (GSK), a global research-based pharmaceutical and healthcare company, announced a regulatory submission to the FDA for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes. 

More... »

PatientsLikeMe, AKU Society to develop first open registry for alkaptonuria patients

Monday, January 14, 2013 01:52 PM

PatientsLikeMe, a patient network that helps improve lives and a real-time research platform that advances medicine, and the AKU Society, which helps patients with alkaptonuria (AKU), raises awareness and supports research into its treatment, are working together to create the first open, global registry for patients with AKU, one of the world's rarest diseases and the first genetic disease discovered.

More... »

INC Research select goBalto to enhance clinical study startup solution

Monday, January 14, 2013 12:31 PM

INC Research, a therapeutically-focused CRO, has selected a global site activation solution from goBalto, a developer of new-generation web clinical research solutions. goBalto Tracker 2.0 is a secure, web-based platform that enables study teams to track and manage site activation activities in clinical trials.

More... »

Horizon, Boehringer Ingelheim enter oncology research service collaboration

Monday, January 14, 2013 11:36 AM

Horizon Discovery, a provider of research tools to support the development of personalized medicines has signed a research service collaboration agreement with Germany-based Boehringer Ingelheim.

More... »

ICON appoints Howie as chief marketing officer

Monday, January 14, 2013 11:07 AM

Icon,a global provider of outsourced development services, has named Robert L. Howie, Jr. as its new chief marketing officer. 

More... »

Cerner, Icon partner to streamline late-phase research studies

Monday, January 14, 2013 09:14 AM

Cerner, a global innovator in electronic health record (EHR) and research technology, and global CRO Icon have formed an agreement to provide pharmaceutical and device sponsors with late-phase research technology to streamline the collection of information related to the safety, effectiveness and value of their medical products.

More... »